| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |